SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-013119
Filing Date
2024-04-04
Accepted
2024-04-04 08:40:16
Documents
15
Period of Report
2024-04-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48504
2 ex99-1.htm EX-99.1 13774
  Complete submission text file 0001493152-24-013119.txt   295570

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE tcbp-20240401.xsd EX-101.SCH 3962
4 XBRL DEFINITION FILE tcbp-20240401_def.xml EX-101.DEF 27421
5 XBRL LABEL FILE tcbp-20240401_lab.xml EX-101.LAB 37884
6 XBRL PRESENTATION FILE tcbp-20240401_pre.xml EX-101.PRE 26038
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6815
Mailing Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR
Business Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR 01414337557
TC BioPharm (Holdings) plc (Filer) CIK: 0001872812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41231 | Film No.: 24821743
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)